Clinical
P
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Approves Pritelivir for Refractory Mucocutaneous HSV in Immunocompromised Adults
2
EADV 2026 Atopic Dermatitis Highlights: Tilrekimig, RAC2 Inhibition, and Level Up Data
3
GLP-1 Agonists Address Metabolic Risk in Psoriatic Disease
4
EB06 Phase 2 Vitiligo Study Receives FDA IND Clearance
5